Featured Speaker: Matthew Hewitt, PhD, Head of R&D (a.i.) and Clinical Development, Personalized Medicine, Lonza, and Stacey Willard, PhD, Director of Product Management, IsoPlexis
Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.
In this Webinar we discuss:
Learn how our unique technology is playing a critical part in advancing cellular immunotherapy
Discover how IsoPlexis is changing the way cell therapies are developed & manufactured
Review several publications & case studies
